Pioneering Researcher Dr. Jeff Geschwind, MD, drives innovation in cancer treatment. His research at NAMSA's core lab and through Cage Pharma focuses on developing novel therapies, including targeting tumor metabolism, pushing the boundaries of modern interventional oncology and drug development. https://medicine.yale.edu/news/medicineatyale/article/two-clinical-leaders-join-medical-school-as-administrators/